Omnicell (OMCL) Tops Q4 EPS by 1c

Omnicell (NASDAQ: OMCL) reported Q4 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $130.3 million versus the consensus estimate of $126.89 million.

GUIDANCE:

Omnicell sees FY2016 EPS of $1.50-$1.60, versus the consensus of $1.57. Omnicell sees FY2016 revenue of $695-715 million, versus the consensus of $572.0 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c